What is Sam on an echo?

Systolic anterior motion (SAM) is defined as displacement of the distal portion of the anterior leaflet of the mitral valve toward the left ventricular outflow tract obstruction.

What causes Sam echo?

These findings suggest that SAM is due to the motion of chordae tendineae and/or papillary muscles traversing the single dimensional ultrasonic beam in systole, thus producing single linear or multiple spotty echoes within SAM.

What is Sam and Lvot?

Left ventricular outflow tract (LVOT) obstruction with systolic anterior motion (SAM) of mitral valve is not only limited to patients with hypertrophic cardiomyopathy. A diagnosis of LVOT obstruction with SAM is important because conventional inotropic support may potentially aggravate hemodynamic deterioration.

What causes systolic anterior motion of the mitral valve?

Systolic anterior motion is a result of complex geometric interaction between mitral valve components requiring significant Venturi and drag forces in the presence of good functioning left ventricle (LV). Disruption in dynamic mitral valvular apparatus, eg, after mitral valve repair can produce SAM.

Does Sam cause mitral regurgitation?

The SAM can result in severe left ventricular outflow tract obstruction and/or mitral regurgitation and is associated with an up to 20% risk of sudden death (which is substantially lower in hypertrophic cardiomyopathy (HCM)).

How is hypertrophic cardiomyopathy detected?

Echocardiogram. An echocardiogram is commonly used to diagnose hypertrophic cardiomyopathy. This test uses sound waves (ultrasound) to see if your heart’s muscle is abnormally thick. It also shows how well your heart’s chambers and valves are pumping blood.

What causes Sam in HCM?

Abbreviations. Systolic anterior motion (SAM) of the mitral valve is the cause of dynamic outflow obstruction in most patients with hypertrophic cardiomyopathy (HCM). There is agreement that SAM is caused by the action of left ventricular (LV) flow on the protruding mitral valve leaflet (1).

Can you have Sam without HOCM?

Systolic anterior motion (SAM) of the mitral valve leaflet has been well-described among patients with hypertrophic cardiomyopathy (HCM); however, this phenomenon also occurs in a population of patients without HCM.

Is systolic anterior motion serious?

What is Sam cardiomyopathy?

Systolic anterior motion (SAM) of the mitral valve (MV) can be a life-threatening condition. The SAM can result in severe left ventricular outflow tract obstruction and/or mitral regurgitation and is associated with an up to 20% risk of sudden death (which is substantially lower in hypertrophic cardiomyopathy (HCM)).

Does cardiomyopathy show on ECG?

Electrocardiogram (EKG or ECG): An EKG records the heart’s electrical activity, showing how fast the heart is beating and whether its rhythm is steady or irregular. An EKG can detect cardiomyopathy as well as other problems, including heart attacks, arrhythmias (abnormal heartbeats) and heart failure.

When is hypertrophic cardiomyopathy diagnosed?

HCM patients can be diagnosed at any age, from birth to age 80+, there are even cases of those in their 90’s with new diagnoses. Although hypertrophy may be present at birth or in childhood, it is much more common for the heart to appear normal then.

What is chordal Sam?

Chordal SAM was defined as systolic anterior motion involving only the chordae tendineae (Fig. 2) [31]. The LVOT area was calculated from the length of the LOVT in the parasternal long- axis view at early systole.

How is systolic anterior motion treated?

A stepwise approach is advocated consisting of medical therapy, followed by aggressive volume loading and beta-adrenoceptor blockade. Surgery is the final option. The correct choice of surgical technique requires an understanding of the anatomical substrate of SAM.

What does cardiomyopathy look like on ECG?

The classic ECG finding in hypertrophic obstructive cardiomyopathy is large dagger-like “septal Q waves” in the lateral — and sometimes inferior — leads due to the abnormally hypertrophied interventricular septum. Criteria for left ventricular hypertrophy is usually present.

What is the most common ECG finding in a patient with cardiomyopathy?

The ECG is abnormal in over 90 percent of patients with hypertrophic cardiomyopathy. The most common abnormalities are left ventricular hypertrophy, ST-segment alterations, T-wave inversion, large Q waves and the peculiar diminution of R waves in the lateral precordial leads seen in this patient.”

Can an echocardiogram detect hypertrophic cardiomyopathy?

An echocardiogram is commonly used to diagnose hypertrophic cardiomyopathy. This test uses sound waves (ultrasound) to see if the heart’s muscle is unusually thick. It also shows how well the heart’s chambers and valves are pumping blood. Electrocardiogram (ECG or EKG).

What is normal Lvot gradient?

LVOT obstruction is defined as a peak instantaneous gradient greater than or equal to 30 mm Hg. A gradient greater than or equal to 50 mm Hg is generally recognized as the threshold at which LVOT obstruction becomes hemodynamically significant.

How is Sam diagnosed and treated?

Echocardiography is vital in making the diagnosis. Listen out for a loud systolic murmur! Management of SAM includes early recognition and treatment. Initial medical management include: Volume expansion, Cease inotropes and rate control, vasoconstrictor. More often, volume replacement is usually adequate.

What is Sam in systole?

This paradoxical movement of the mitral valve in systole is called SAM and is usually associated with HCM (hypertrophic cardiomyopathy) but has been found to be present in patients who are hypertensive, diabetic ( with LV hypertrophy), and even in asymptomatic patients. It is a dynamic obstruction.

What are the independent predictors of subarachnoid hemorrhage (Sam)?

We found that the independent predictors of SAM were a smaller left ventricle, enlarged interventricular septum, short coaptation to septum distance, narrow aorto-mitral angle and a tall posterior leaflet.

What are independent predictors of surgical site atrophy (Sam)?

Independent predictors of SAM were identified using multiple logistic regression analysis. Of the 375 patients, 345 (92%) did not develop SAM (No-SAM group), while 30 (8%) developed intraoperative or postoperative SAM (SAM group). The mean age was 56.8 ± 12.8 and 56.7 ± 13.8 in the No-SAM and SAM groups, respectively.

https://www.youtube.com/watch?v=Kplt9wqS5b0